These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14235549)

  • 1. INTERACTION OF STREPTOKINASE AND HUMAN PLASMINOGEN. I. COMBINING OF STREPTOKINASE AND PLASMINOGEN OBSERVED IN THE ULTRACENTRIFUGE UNDER A VARIETY OF EXPERIMENTAL CONDITIONS.
    DAVIES MC; ENGLERT ME; DERENZO EC
    J Biol Chem; 1964 Aug; 239():2651-6. PubMed ID: 14235549
    [No Abstract]   [Full Text] [Related]  

  • 2. ACTIVATION OF PARTIALLY PURIFIED PLASMINOGEN IN THE PRESENCE OF EPSILON-AMINOCAPROIC ACID. A TECHNIQUE FOR PREPARING PLASMIN FREE OF EXTRINSIC ACTIVATORS.
    DONALDSON VH
    J Lab Clin Med; 1964 Feb; 63():213-23. PubMed ID: 14125108
    [No Abstract]   [Full Text] [Related]  

  • 3. INTERACTION OF STREPTOKINASE AND HUMAN PLASMINOGEN. II. STARCH GEL ELECTROPHORETIC DEMONSTRATION OF A REACTION PRODUCT WITH ACTIVATOR ACTIVITY.
    BARG WF; BOGGIANO E; DERENZO EC
    J Biol Chem; 1965 Jul; 240():2944-50. PubMed ID: 14342318
    [No Abstract]   [Full Text] [Related]  

  • 4. [LEUKOCYTIC FIBRINOLYSIS].
    CAVIEZEL O; VOLLERY M; VANNOTTI A
    Schweiz Med Wochenschr; 1964 Jul; 94():1016-20. PubMed ID: 14243603
    [No Abstract]   [Full Text] [Related]  

  • 5. ROLE OF INHIBITORS OF FIBRINOLYSIS IN HEPATIC CIRRHOSIS.
    O'CONNELL RA; GROSSI CE; ROUSSELOT LM
    Lancet; 1964 Nov; 2(7367):990-1. PubMed ID: 14201669
    [No Abstract]   [Full Text] [Related]  

  • 6. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY].
    DOUGLAS AS; MCNICOL GP
    Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145
    [No Abstract]   [Full Text] [Related]  

  • 7. THROMBOLYTIC THERAPY.
    DOUGLAS AS; MCNICOL GP
    Proc R Soc Med; 1964 Jul; 57(7):609-14. PubMed ID: 14178954
    [No Abstract]   [Full Text] [Related]  

  • 8. THROMBOLYSIS STUDIED IN AN ARTIFICIAL CIRCULATION: THROMBI PREPARED IN VITRO IN A CHANDLER'S TUBE.
    MCNICOL GP; BAIN WH; WALKER F; RIFKIND BM; DOUGLAS AS
    Lancet; 1965 Apr; 1(7390):838-42. PubMed ID: 14263541
    [No Abstract]   [Full Text] [Related]  

  • 9. INACTIVATION OF ACTH BY HUMAN PLASMIN SYSTEM AND EFFECT OF PLASMIN INHIBITORS.
    YAMAMURA Y; KUMAGAI A; TAKEUCHI K; MORIMOTO Y; ASANUMA Y; UEMURA T
    Endocrinol Jpn; 1964 Sep; 11():209-15. PubMed ID: 14279625
    [No Abstract]   [Full Text] [Related]  

  • 10. CLINICAL TRIAL OF EPSILON-AMINOCAPROIC ACID IN SEVERE HAEMOPHILIA.
    GORDON AM; MCNICOL GP; DUBBER AH; MCDONALD GA; DOUGLAS AS
    Br Med J; 1965 Jun; 1(5451):1632-5. PubMed ID: 14295319
    [No Abstract]   [Full Text] [Related]  

  • 11. THROMBOLYTIC THERAPY.
    DOUGLAS AS; MCNICOL GP
    Br Med Bull; 1964 Sep; 20():228-32. PubMed ID: 14209763
    [No Abstract]   [Full Text] [Related]  

  • 12. THE INHIBITION OF TRASYLOL OF FIBRINOLYTIC ACTIVITY ASSOCIATED WITH CARDIOVASCULAR OPERATIONS.
    TICE DA; WORTH MH; CLAUSS RH; REED GH
    Surg Gynecol Obstet; 1964 Jul; 119():71-4. PubMed ID: 14179354
    [No Abstract]   [Full Text] [Related]  

  • 13. SOME PROPERTIES OF THE ANTIFIBRINOLYTICALLY ACTIVE ISOMER OF AMINO-METHYLCYCLOHEXANE CARBOXYLIC ACID.
    DUBBER AH; MCNICOL GP; DOUGLAS AS; MELANDER B
    Lancet; 1964 Dec; 2(7373):1317-9. PubMed ID: 14224037
    [No Abstract]   [Full Text] [Related]  

  • 14. THE ASSAY OF UROKINASE PREPARATIONS FOR CONTAMINATION WITH THROMBOPLASTIC MOIETIES.
    ALKJAERSIG N; FLETCHER AP; SHERRY S
    J Lab Clin Med; 1965 May; 65():732-8. PubMed ID: 14281369
    [No Abstract]   [Full Text] [Related]  

  • 15. INHIBITION OF FIBRINOLYSIS AND FIBRINOGENOLYSIS IN MAN: COMPARISON OF EPILSON-AMINOCAPROIC AID AND KALLIKREIN INHIBITOR.
    BECK E; SCHMUTZLER R; DUCKERT F
    Thromb Diath Haemorrh; 1963 Nov; 10():106-19. PubMed ID: 14081273
    [No Abstract]   [Full Text] [Related]  

  • 16. [EPSILON-AMINOCAPROIC ACID AND FIBRINOLYSIS].
    VAIREL E; LANDE M; LEGER L
    Presse Med (1893); 1964 Mar; 72():945-6. PubMed ID: 14119753
    [No Abstract]   [Full Text] [Related]  

  • 17. ACTION OF THE NEW ANTI-FIBRINOLYTIC SUBSTANCE ON THE STREPTOKINASE-ACTIVATED PROTEASES (PLASMINS).
    MIHARA H
    Kobe J Med Sci; 1963 Dec; 18():169-77. PubMed ID: 14160537
    [No Abstract]   [Full Text] [Related]  

  • 18. STUDIES ON THE CLOT-PROMOTING EFFECT OF LARGE CONCENTRATIONS OF STREPTOKINASE.
    GODAL HC; HELLE I
    Scand J Clin Lab Invest; 1963; 15():375-9. PubMed ID: 14073286
    [No Abstract]   [Full Text] [Related]  

  • 19. [60 YEARS OF FIBRINOLYSIS].
    MARCHAL G
    Hemostase; 1963; 3():101-4. PubMed ID: 14050807
    [No Abstract]   [Full Text] [Related]  

  • 20. INTRAVASCULAR CLOTTING AND SPONTANEOUS FIBRINOLYSIS.
    KOLLER F
    Acta Haematol; 1964 Apr; 31():239-46. PubMed ID: 14169390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.